FDA
-
-
-
-
-
-
-
Aurinia names board chair Kevin Tang as new CEO
-
-
-
-
-
-
-
Aurinia Announces Upcoming Presentations of New Data on LUPKYNIS® at American College of Rheumatology Convergence and American Society of Nephrology Kidney Week 2025
-
-
-
-
-
-
-
Aurinia Pharmaceuticals (AUPH) Announces Positive Results from Phase 1 Study of Aritinercept (AUR200)
-
-
-
-
-
-
-
ISS Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting
-
-
-
-
-
-
-
Aurinia Pharmaceuticals Appoints Craig Johnson to Board of Directors to Support Next Phase of Growth
-
-
-
-
-
-
-
Aurinia to Participate in 2024 Cantor Fitzgerald Global Healthcare Conference
-
-
-
-
-
-
-
venBio Raises $528 Million Venture Capital Fund Focused on Life Science Companies
-
326,418 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

